World's Best Scientists 2026 revealed!
Severo Salvadori

Severo Salvadori

D-Index & Metrics

Biology and Biochemistry

D-Index
62
Citations
13855
World Ranking
10792
National Ranking
305

Chemistry

D-Index
62
Citations
13479
World Ranking
8838
National Ranking
240

Severo Salvadori publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Severo Salvadori sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 313 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Severo Salvadori D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Severo Salvadori sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 62 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Severo Salvadori is affiliated with the University of Ferrara in Italy. Their research output includes work published in recognized academic venues, with a focus on clinical oncology as illustrated by recent studies.

One notable publication by Salvadori is titled "388P Long-term outcomes of intraoperative radiotherapy (IORT) in early breast cancer (eBC)." This paper was published in 2025 in the journal Annals of Oncology. The research addresses the application and effects of intraoperative radiotherapy in treating early breast cancer, contributing to the clinical understanding of this treatment approach.

Salvadori frequently collaborates with several coauthors, reflecting a network of joint research efforts. These coauthors include:

  • Vittoria Fotia
  • L. Maffioletti
  • Silvio Sporeni
  • Eleonora Mauri
  • E. Vitali

The publication venue associated with Salvadori is:

  • Annals of Oncology

Although information about primary fields of study, subfields, and main topics of work is not explicitly detailed in the available data, the nature of the recent publication indicates a research focus related to oncology and clinical cancer treatment methodologies.

The body of work suggests active engagement with research on cancer therapies, particularly examining radiotherapy techniques and their long-term outcomes. This aligns with the scientific and medical priorities of specialized oncology research, especially considering Salvadori's connection to the University of Ferrara, an institution known for contributions in the biomedical sciences.

Best Publications

  • The Tachykinin Peptide Family

    Cinzia Severini;Giovanna Improta;Giuliana Falconieri-Erspamer;Severo Salvadori

  • Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.

    Orlando Crescenzi;Simona Tomaselli;Remo Guerrini;Severo Salvadori

  • Pharmacology of nociceptin and its receptor: a novel therapeutic target

    Girolamo Calo;Remo Guerrini;Anna Rizzi;Severo Salvadori

  • A new selective antagonist of the nociceptin receptor

    Remo Guerrini;Girolamo Calo;Anna Rizzi;Raffaella Bigoni

  • Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.

    Remo Guerrini;Girolamo Calo;Anna Rizzi;Clementina Bianchi

  • Characterization of [Nphe1]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist

    Girolamo Calo;Remo Guerrini;Raffaella Bigoni;Anna Rizzi

  • Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice

    A Rizzi;R Vergura;G Marzola;C Ruzza

  • [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.

    Girolamo Calo;Anna Rizzi;Daniela Rizzi;Raffaella Bigoni

  • Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile

    ND Dietis;R Guerrini;G Calo;s Salvadori

  • Solution structure of amyloid beta-peptide (25-35) in different media.

    Anna M D'Ursi;Maria R Armenante;Remo Guerrini;Severo Salvadori

  • Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.

    S Salvadori;M Attila;G Balboni;C Bianchi

  • Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.

    Matteo Marti;Flora Mela;Carlo Veronesi;Remo Guerrini

  • The mouse vas deferens: a pharmacological preparation sensitive to nociceptin.

    Girolamo Calò;Anna Rizzi;Giovanni Bogoni;Vitold Neugebauer

  • Blockade of Nociceptin/Orphanin FQ Transmission Attenuates Symptoms and Neurodegeneration Associated with Parkinson's Disease

    Matteo Marti;Flora Mela;Martina Fantin;Silvia Zucchini

  • Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.

    E. C. Gavioli;G. Marzola;R. Guerrini;R. Bertorelli

  • Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay.

    G Calò;A Rizzi;G Marzola;R Guerrini

  • Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.

    Remo Guerrini;Severo Salvadori;Anna Rizzi;Domenico Regoli

  • Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways.

    Fabio L. M. Ricciardolo;Martin Steinhoff;Martin Steinhoff;Martin Steinhoff;Silvia Amadesi;Silvia Amadesi;Silvia Amadesi;Remo Guerrini;Remo Guerrini;Remo Guerrini

  • Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.

    Raffaella Bigoni;Sandro Giuliani;G. Calo;Anna Rizzi

  • Evaluation of the Dmt-Tic pharmacophore: Conversion of a potent δ-opioid receptor antagonist into a potent δ agonist and ligands with mixed properties

    Gianfranco Balboni;Remo Guerrini;Severo Salvadori;Clementina Bianchi

Frequent Co-Authors

Remo Guerrini
Remo Guerrini University of Ferrara
Girolamo Calo
Girolamo Calo University of Ferrara
Domenico Regoli
Domenico Regoli University of Ferrara
Lawrence H. Lazarus
Lawrence H. Lazarus National Institutes of Health
Piero A. Temussi
Piero A. Temussi University of Naples Federico II
Rainer K. Reinscheid
Rainer K. Reinscheid University of California, Irvine
Pier Andrea Borea
Pier Andrea Borea University of Ferrara
Michele Morari
Michele Morari University of Ferrara
Ying Xia
Ying Xia Fudan University
Géza Tóth
Géza Tóth University of the Basque Country

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Chemistry opens various paths not only in traditional science roles but also in diverse fields requiring a strong analytical background. Online programs, such as an online associates in criminal justice, demonstrate how chemistry skills can overlap with forensic science and legal investigations.

For those interested in law-related careers, understanding different types of paralegal education is valuable. Exploring paralegal salary information helps highlight the earning potential and growth opportunities outside pure science roles. Paralegal work can be a complementary career path for chemists interested in patent law or regulatory compliance.

Chemistry graduates can also thrive in the healthcare industry. Becoming a pharmaceutical sales representative is one option that blends scientific knowledge with business skills. Learning about how much do pharmaceutical sales reps make provides insight into the lucrative prospects and career advancement in this sector.

For those committed to advanced study, there are clear steps to become a pharmacist, illustrating another rewarding path where chemistry expertise is essential. Pharmacists play a crucial role in healthcare, offering stability and growth for graduates.

Best Scientists Citing Severo Salvadori

Trending Scientists

Recently Published Articles